Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study
Authors
Keywords
-
Journal
Journal of Digestive Diseases
Volume 16, Issue 11, Pages 665-674
Publisher
Wiley
Online
2015-10-17
DOI
10.1111/1751-2980.12294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Race influences warfarin dose changes associated with genetic factors
- (2015) N. A. Limdi et al. BLOOD
- Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose
- (2015) Hirotsugu Kenmotsu et al. CANCER SCIENCE
- Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage, Based on Child–Pugh Class, and Effects of Antibiotics
- (2015) Puneeta Tandon et al. Clinical Gastroenterology and Hepatology
- Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia
- (2015) Georgios N. Kalambokis et al. LIVER INTERNATIONAL
- Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis
- (2014) J. S. Bajaj et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis
- (2014) J. S. Bajaj et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mining the Metabiome: Identifying Novel Natural Products from Microbial Communities
- (2014) Aleksandr Milshteyn et al. CHEMISTRY & BIOLOGY
- Purinergic signaling via P2Y receptors up-mediates IL-6 production by liver macrophages/Kupffer cells
- (2014) Makiko Ishimaru et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Liver cirrhosis
- (2014) Emmanuel A Tsochatzis et al. LANCET
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives
- (2014) Giulia Malaguarnera WORLD JOURNAL OF GASTROENTEROLOGY
- Toxic epidermal necrolysis associated with rifaximin
- (2013) A. S. Patel et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats
- (2013) Dabo Xu et al. GASTROENTEROLOGY
- Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2013) Philipp Zanger et al. LANCET INFECTIOUS DISEASES
- Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
- (2013) Jasmohan S. Bajaj et al. PLoS One
- The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization
- (2013) M.A. Kane et al. VACCINE
- Probable rifaximin-induced neutropenia
- (2012) L. M. Hynicka et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
- (2012) Jasmohan S. Bajaj et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
- (2012) Jiannis Vlachogiannakos et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
- (2012) Cheng-Yuan Peng et al. JOURNAL OF HEPATOLOGY
- Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats
- (2012) Gemma Òdena WORLD JOURNAL OF GASTROENTEROLOGY
- Rifaximin: New Therapeutic Indication and Future Directions
- (2011) Anastasia Rivkin et al. CLINICAL THERAPEUTICS
- Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt
- (2011) Jonel Trebicka et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Characterization of fecal microbial communities in patients with liver cirrhosis
- (2011) Yanfei Chen et al. HEPATOLOGY
- Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice
- (2011) Qiang Zhu et al. JOURNAL OF HEPATOLOGY
- The role of intestinal endotoxin in liver injury: A long and evolving history
- (2010) James P. Nolan HEPATOLOGY
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis
- (2010) JOURNAL OF HEPATOLOGY
- Rifaximin Treatment in Hepatic Encephalopathy
- (2010) Nathan M. Bass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Probiotics and gut health: A special focus on liver diseases
- (2010) Silvia Wilson Gratz WORLD JOURNAL OF GASTROENTEROLOGY
- Liver cirrhosis
- (2008) Detlef Schuppan et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now